MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 592620 | Name: Pirifibrate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Pirifibrate is used in the treatment of hyperlipoproteinemia.

Chemical Structure

Pirifibrate
Pirifibrate
CAS#21550-30-1

Theoretical Analysis

MedKoo Cat#: 592620

Name: Pirifibrate

CAS#: 21550-30-1

Chemical Formula: C17H19Cl2NO4

Exact Mass: 371.0691

Molecular Weight: 372.24

Elemental Analysis: C, 54.85; H, 5.15; Cl, 19.05; N, 3.76; O, 17.19

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Pirifibrate; Bratenol
IUPAC/Chemical Name
(6-(Hydroxymethyl)-2-pyridyl)methyl 2-(4-chlorophenoxy)-2-methylpropionate hydrochloride
InChi Key
XVHPKZBGSLSNOT-UHFFFAOYSA-N
InChi Code
InChI=1S/C17H18ClNO4.ClH/c1-17(2,23-15-8-6-12(18)7-9-15)16(21)22-11-14-5-3-4-13(10-20)19-14;/h3-9,20H,10-11H2,1-2H3;1H
SMILES Code
CC(C)(OC1=CC=C(Cl)C=C1)C(OCC2=NC(CO)=CC=C2)=O.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 372.24 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Lopez Rodriguez J, Martorell J. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV. Clin Ther. 1980;3(4):234-41. PubMed PMID: 7273061. 2: Bonora V, Calalabuig RJ, Caviola E, Soler J, Pueyo JM, Micaló T, Cano RP. Treatment of hyperlipoproteinemia, types II and IV, with pirifibrate: one hundred observations. Clin Ther. 1981;4(3):192-200. PubMed PMID: 7030489. 3: Domingo AJ, Gutiérrez JA, Menéndez JA, Micó L, Muñoz M, de Oya M. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study. Clin Ther. 1980;3(3):219-26. PubMed PMID: 7459931. 4: de la Fuente R, Santos M. [Toxicological and pharmacological studies on a new drug: pirfibrate (EL-466) (author's transl)]. Arch Farmacol Toxicol. 1980 Dec;6(3):255-64. Spanish. PubMed PMID: 7305456.